Amgen Incorporated · Round Rock, Texas
Case #I-200-21215-499940
In FY2021, Amgen Incorporated sought H-1B sponsorship for a Global Early Clinical Development Manager 20516.190.7 in Round Rock, Texas at $139k per year, which is 20% above the prevailing wage of $116k. The case was certified in 23 days during the FY FY2021 cycle. This position is for continued employment.
| Case Number | I-200-21215-499940 |
| Case Status | Certified - Withdrawn |
| Visa Class | H-1B |
| Fiscal Year | FY 2021 |
| Employer | Amgen Incorporated |
| Employer Location | Thousand Oaks, California |
| Job Title | Global Early Clinical Development Manager 20516.190.7 |
| SOC Code | 11-912100 – Natural Sciences Managers |
| Worksite | Round Rock, Texas |
| Annual Wage | $139k |
| Prevailing Wage | $116k |
| Wage Premium | +20.3% |
| Positions | 1 (0 new, 0 continued) |
| Job Title | Salary | Status | Date |
|---|---|---|---|
| Sr. Associate HR Systems & Solutions 20516.4452 | $93k | CERTIFIED | Nov 1, 2024 |
| Regulatory Affairs Mgr 20516.3950.8 | $129k | CERTIFIED | May 10, 2024 |
| Senior Associate Scheduler 20516.404 | $97k | CERTIFIED | Jul 26, 2024 |
| Process Development Senior Scientist 20516.3082.9 | $140k | CERTIFIED | Jun 27, 2024 |
| Specialist Business Analyst 20516.835.10 | $112k | CERTIFIED | Jun 19, 2024 |
This Labor Condition Application (LCA) was filed by Amgen Incorporated for the position of Global Early Clinical Development Manager 20516.190.7 in Round Rock, Texas. The offered annual salary is $139k, compared to the prevailing wage of $116k for this occupation and location. This represents a wage premium of +20.3% above the prevailing wage.
The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.
Case status: Certified - Withdrawn. This means the employer or their representative withdrew the application.
A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.
When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, Amgen Incorporated filed LCA case number I-200-21215-499940 to sponsor a Global Early Clinical Development Manager 20516.190.7 position at their worksite in Round Rock, Texas. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.
The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:
For this filing, the offered wage of $139k compares to the DOL prevailing wage of $116k for Natural Sciences Managers positions in the Round Rock, Texas area. The positive wage premium of +20.3% indicates the employer is offering above the DOL-determined average for this occupation and location.
The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.
A "Certified-Withdrawn" status means this LCA was initially certified by the DOL but was later withdrawn by the employer. This can happen for various reasons: the foreign worker may have declined the position, found employment elsewhere, the employer may have decided to refile with updated information, or business conditions may have changed. A withdrawal does not negatively affect the employer's ability to file future LCAs.
This LCA was received by the DOL on Aug 3, 2021 and a decision was rendered on Aug 26, 2021, a processing time of approximately 23 business days. The standard DOL processing time for LCA applications is 7 to 10 business days. This application took longer than the standard timeframe, which may indicate additional review was required.
The offered salary of $139k for this Global Early Clinical Development Manager 20516.190.7 position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 11-912100 (Natural Sciences Managers), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.
The offered annual salary for this Global Early Clinical Development Manager 20516.190.7 position at Amgen Incorporated is $139k. The Department of Labor prevailing wage for this occupation and location is $116k. The offered wage represents a +20.3% premium over the prevailing wage.
This H-1B filing is for a position located in Round Rock, Texas. The employing company, Amgen Incorporated, is headquartered in Thousand Oaks, California.
This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.
The employer for this filing is Amgen Incorporated, located in Thousand Oaks, California. Amgen Incorporated filed this Labor Condition Application (case number I-200-21215-499940) for a Global Early Clinical Development Manager 20516.190.7 position during fiscal year FY 2021. View all Amgen Incorporated H-1B filings.
Certified-Withdrawn means this LCA was initially certified by the DOL but was subsequently withdrawn by the employer or their authorized representative.